One ‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study

ConclusionsImplantation of the AFR device in HF patients was feasible. No shunt occlusion, stroke or new right HF was observed during the 1 ‐year follow‐up, with clinical improvements in certain patients.

Source: European Journal of Heart Failure - March 6, 2021 Category: Cardiology Authors: Christina Paitazoglou, Martin W. Bergmann, Ramazan Özdemir, Roman Pfister, Jozef Bartunek, Teoman Kilic, Alexander Lauten, Alexander Schmeisser, Mehdi Zoghi, Stefan D. Anker, Horst Sievert, Felix Mahfoud, AFR‐PRELIEVE Investigators Tags: Research Article Source Type: research